Thank you, everyone. Thank you. You can hear me correct? It's good? Okay, perfect. Just scroll down. Scroll down. Here, here we go. Okay. And today, my topic is jumping into social media and medicine as a newbie, spectrum of benefits. So the funny thing is that I don't know why I'm here, like how did I get here? Being an accidental tourist and all this stuff that actually talking here is quite nerve wracking for me because I'm a very private person, don't even have a Facebook account, and here I am tweeting very comfortably. How did this happen? How did I... And I am that category D, it's not the beginning career towards the end career. So this all... I'm gonna tell you about my journey, how did I use this? I don't have any disclosures. My objective is today, how did I utilize the social media? Telling my own story for clinical support, for research, for education, for public health, for advocacy, for well being, and that's what I'll try to do in the next 10 minutes. And how it started, quite pathetic. I use the social media as a newspaper because that's how I grow up. Like, you know, I get a magazine and you just open it up every two months, look at the nice picture and then, you know, just stop it. And then what happened? It was a unilateral use. Then it was, I think, that was a reunion, a Hopkins reunion, for five years ago, and Sapna was giving this talk, Dr. Kuchatkar was giving this talk about how to use social media, how to utilize it, what to do. I came back home from Baltimore, I live in Los Angeles, okay, I'm gonna do this the right way, not like how I was doing before. So, what did I change? I changed that I actually put my full name and use the space as a business card, that's like new version of a business card. Okay, my name, what do I do, what kind of a doctor I am, which institution I work, a link to my institution. And since I am bilingual, I just add there like a sentence that says, Çocuk Yoğun Bakım means Pediatric Critical Care in Turkish. And then I have couple interests, research interests, like iron, anemia, pediatric acute liver failure. I added those and tagged the... When I tweet, I tag the correct people, the journals, the link to papers, and a summary sentence so that the attention span of the scroller is two seconds, how could I just get the attention? So, that's what I tried to do. And I followed Sapna's basic social media rules, that's to the T, everything. So, don't ever sacrifice collegiality due to a difference of opinion, don't ever give specific medical advice or try to diagnose online, don't write about actual patients or cases, don't forget to cite the source, don't post slides of unpublished data without permission, and remember that a post lasts a lifetime, may come find you. So, initially, it was the... My drive was research. I work in an iron lab and then I want everybody to love iron and how cool this is, it's the start of the life world, everything. So, our lab did not have a handle, so I learned what a handle is, a hashtag is all that from Sapna, by the way. And then I created this UCLA Center for Iron Disorders and I linked to the website of the lab. And every time I had a publication or every time I have a paper or I kept... Because that was the part that I felt the most comfortable. I just tagged the iron, hepcidin, iron biology, and not many people were interested, so I felt comfortable in my corner of the iron there. And I just tagged AABB and NATO because those are the... Aligned with my research. And if I'm gonna give a conference, I'll make sure that I wrote about it before I gave the time, what is it about, and I advertised it. Then the COVID hit 2020, and then all of a sudden, I couldn't go to library, especially for the children, there wasn't enough information. I couldn't just go to library or ask my lovely Pete's idea folks to say, what do I do? Where do I find the masks? How do I sterilize that? How do I get a nursing protocol? Which form do you guys use in your ICU? Which one communicates between inside of the room, outside of the room? It was the specific, very simple things that we started discussing. And all of a sudden, I get up in the morning, I'm not looking at the newspaper anymore, I look at this. Pete's ICU, hashtag, COVID-19 hashtag. Let's see what's happening in the world, in my world of ICU. Who discovered what? What are we gonna do about this COVID business? So that's how I hooked up. And also, since being bilingual, I just started tweeting also in Turkish and tried to capture some attention when I had the vaccination, or I put a picture about the ventilation, the masks, and the children, and then a couple of the news articles, the journals that they picked up. So I was doing dual tweeting. But I cannot have this talk without talking about MIS-C. MIS-C is Multisystem Inflammatory Syndrome in Children, MIS-C. In April 29 of 2020, a couple of the UK intensivists noticed that there are really sick children, they don't look like really exactly Kawasaki, they don't look like Toxic Shock Syndrome, they're just something in between, but there's a relationship to the COVID. So they named this PIMSDS, Pediatric Inflammatory Multisystem Syndrome Temporarily Associated with COVID, and they tweeted. This is in April 26, and the next day, the April 27, there was a 25,000 retweets, and we are all talking about it. And this just exponentially spread. And in US, we didn't see MIS-C then, and then by May, a couple of weeks later, we were all talking about MIS-C. It was in the news articles, these children are coming and dying in two days, how are we gonna treat this? What is the syndrome? This is not being seen in the adults. So this is all we talked about. But we could have not learned about this many, many months if we didn't have this tool. And Dr. Kuchatkar, I published at Pediatric Critical Care Medicine, that how we utilize this social media tool for dissemination of correct information, how we helped to diagnose children much quicker. It wasn't this mysterious MIS-C anymore, we know more about that. Then that intrigued me, and then I started reading anything and everything about MIS-C, MIS-C's diagnosis, differential immunology, immunopathology, and everything. And I started reading and I focused all my attention to a single topic, and that's all I tweeted about MIS-C, and what are we know, what do we know? And the beauty of this was, later then, there came neonatal MIS-C and an adult MIS-C, and you could communicate with the scientists like Dr. Juncker, Dr. Arditti, Dr. Andrea Randolph, that they were doing different aspects of the science, and you could actually direct message them what do they think, a patient with the MIS-C should get a vaccine or not? Should they get it now? Should they wait three months? You could ask these questions, it was very practical for a clinician, and then I shared that experience with everybody. And then, since I was focused on a single topic, this allowed me to collaborate with the like minded people like Dr. Remy, and Carol, and Maser, and Nobrodsky, that we wrote an article about the host immune responses of MIS-C, why we are seeing this, and this was quite a bit of... It's well received, I should say, we had like 200,000 impressions, and I actually ran into Dr. Tasker, who's the Peace Critical Care Medicine Editor in Chief, and I find out that, to my surprise, that this was actually the number two article that has been cited last year. So, I think this is, of course, because of the COVID and all, but also that we amplified our studies. And it's the simple case of, it was just the couple of months after the pandemic, that we are seeing this diabetes in children and DKA, and we wrote a case report, and then all of a sudden, my friends from all over the United States were talking about the similar DKA and diabetes. And this is, you may say a simple case report, but I think this alerted the physicians, if a child comes in with DKA, maybe we should look at their COVID status or not. And it's also fun to see who's reading and which countries you have been reading. This is also fun for me to watch, than when you are publishing. And I also had that interest in pediatric acute liver failure, and I initially wrote a paper, and then I was able to connect with world leaders, such as Dr. Akash Deep from King's College, who traveled from very far, I could see him. And we were able to write papers together, and he's the lead pediatric liver transplant center in King's College in London. We communicated, we wrote papers, and we are actually presenting coagulopathy in acute liver failure tomorrow. So this opened up new windows, new opportunities for someone like me. And the teaching was so much fun. I always love teaching, but I didn't know how to teach, other than where I work. So all of a sudden that I'm like, use this... It's the Instagram spaces, Twitter spaces, and live tweeting. I've never live tweeted, but the people teach you, you ask around, and do you wanna do a live tweeting? I don't know how to live tweet, but if you teach me, I'll do it. Or an Instagram live, I found myself actually presenting my PowerPoint in an Instagram live in Turkish, and reaching quite a bit of people that... Emergency room physicians, pediatricians, asking questions about COVID treatment, MISC. So it just opened up a new area of education that I didn't know. I thought that it was only, I'm gonna prepare my PowerPoint, and I'm gonna give my lecture to my five fellows, and that was it. This was so much fun. And now, that's what we are doing here too, SCCM 2023 and educating. And also, I utilize this for the public health, but I didn't know how to use this for public health. I learned quite a bit of, like, if you're a scientist in your lab, and if you're an intensive care physicians, how does the public health advocacy looks like? I really didn't know that. So I started following Dr. Diana Marie Behrens, I don't know if she's here or not, because she does quite a bit of her work, and I learned so much from her. We wrote a paper, a couple of the intensives together, again with Sapna, in that paper too, a commentary about, urgently about the vaccines and the Delta variants. And now, we continue about the voting for kids, gun violence, vaccine shortages. Three of the international pediatric intensives, again, I connected through Twitter, Dr. Vanessa Lanziotti, Dr. Seba Gonzalez, and Dr. Danilo Bonseno from Italy, Brazil, and Uruguay. We looked at it that there are wonderful vaccines, here we go, Eureka, we have these vaccines, but it's not available for children in lower middle income countries. And it is much, much more important for those countries because they don't have the sophisticated intensive care units, they don't have the oxygen, this and that. So we just wrote this paper because we were feeling frustrated. Every time you're frustrated about something, we started writing something and just put it out there. And why stop in healthcare? Might as well. Advocacy for the gender equity and women in ICU. Here, we wrote an editorial with Dr. Kuchatkar, Miller, Lanziotti, Behrens, Dewan, and Ong. And in this one, we wanted to increase awareness for gender equity, that female authors in academic literature is much less, female leaders is much less. And then the female speakers at conferences, we are doing a good job today though, I'm just seeing that there's no more Manel's that we are representing, it's equally. And then we gave a list of women speakers in that article. And I still continue with this, and then it just comes up because Dr. Bradley Goldberg from LA Children's, I'm at UCLA, just tweeted saying that there's a 16 hour wait, and then we just directly communicated, 16 hour wait, only we are seeing one third of the children. Why this is not at the news? And I was like, why this is not the news? And exactly, I wrote that. Why this is not on national news every night? Let's find a hashtag. He said, okay, Sapna, you are the hashtag queen, just find us a hashtag. So it's like, peace in crisis became the hashtag, and we augmented that, and then suddenly 157 impressions that we wanted to be in the newspapers, we wanted to be in news media, that what is happening for children, what is the triple demyx, that this is quite sad. Well, this is the silver lining for me for the COVID, that we actually did wellness through the Twitter, and a couple of us here that you see, with Sapna, Maya, and Jen, that we did yoga. I've never done yoga in my life, but I said, could you do it? Of course, why not? I can do anything, just try it, I can try something, why not? So this wasn't... Everybody did it on their time, but we kept each other accountable, and this was a wellness tool for me, in a way that just connecting and doing something good for each other. And not in a million year, I would have think about that being called a PEDS ICU influencer. I think this is my best accomplishment ever, ever. So here I am, I'm in this list, and I'm so proud, and I continue the rules that I learned a couple of years ago from Sapna, that I just try to be collegial, and continue to be respectful. And this is my friend, Vanessa Lanziotti from Brazil. When I was tweeting anything and everything about MISC, she came up with this, I think, Ritivit Vachonjo tweets, and with this happy dance, it just became my little thing at that time. This is how many people we were reaching, and I still enjoy. Well, social media will be changing constantly, and we as clinicians, as an intensive care clinicians, we need to pivot, we need to change, we need to adapt, but have a way of communicating. I think if the pandemic teach us one thing, and that's what we learned. Thank you very much for your time.

social media

medicine

research purposes

COVID-19 pandemic

knowledge sharing